272 related articles for article (PubMed ID: 28358655)
1. Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.
Spratt DE; Yousefi K; Deheshi S; Ross AE; Den RB; Schaeffer EM; Trock BJ; Zhang J; Glass AG; Dicker AP; Abdollah F; Zhao SG; Lam LLC; du Plessis M; Choeurng V; Haddad Z; Buerki C; Davicioni E; Weinmann S; Freedland SJ; Klein EA; Karnes RJ; Feng FY
J Clin Oncol; 2017 Jun; 35(18):1991-1998. PubMed ID: 28358655
[TBL] [Abstract][Full Text] [Related]
2. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
[TBL] [Abstract][Full Text] [Related]
3. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
4. Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy.
Spratt DE; Dai DLY; Den RB; Troncoso P; Yousefi K; Ross AE; Schaeffer EM; Haddad Z; Davicioni E; Mehra R; Morgan TM; Rayford W; Abdollah F; Trabulsi E; Achim M; Tapia ELN; Guerrero M; Karnes RJ; Dicker AP; Hurwitz MA; Nguyen PL; Feng FFY; Freedland SJ; Davis JW
Eur Urol; 2018 Jul; 74(1):107-114. PubMed ID: 29233664
[TBL] [Abstract][Full Text] [Related]
5. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
[TBL] [Abstract][Full Text] [Related]
6. Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.
Nguyen PL; Haddad Z; Ross AE; Martin NE; Deheshi S; Lam LLC; Chelliserry J; Tosoian JJ; Lotan TL; Spratt DE; Stoyanova RS; Punnen S; Ong K; Buerki C; Aranes M; Kolisnik T; Margrave J; Yousefi K; Choeurng V; Davicioni E; Trock BJ; Kane CJ; Pollack A; Davis JW; Feng FY; Klein EA
Eur Urol; 2017 Nov; 72(5):845-852. PubMed ID: 28528811
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.
Van den Broeck T; Moris L; Gevaert T; Tosco L; Smeets E; Fishbane N; Liu Y; Helsen C; Margrave J; Buerki C; Davicioni E; Van Poppel H; Everaerts W; Weinmann S; Den R; Davis J; Schaeffer E; Karnes RJ; Claessens F; Joniau S
Eur Urol Oncol; 2019 Sep; 2(5):589-596. PubMed ID: 31411980
[TBL] [Abstract][Full Text] [Related]
8. Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.
Tosoian JJ; Birer SR; Jeffrey Karnes R; Zhang J; Davicioni E; Klein EE; Freedland SJ; Weinmann S; Trock BJ; Dess RT; Zhao SG; Jackson WC; Yamoah K; Dal Pra A; Mahal BA; Morgan TM; Mehra R; Kaffenberger S; Salami SS; Kane C; Pollack A; Den RB; Berlin A; Schaeffer EM; Nguyen PL; Feng FY; Spratt DE
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):646-653. PubMed ID: 32231245
[TBL] [Abstract][Full Text] [Related]
9. Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model.
Dalela D; Santiago-Jiménez M; Yousefi K; Karnes RJ; Ross AE; Den RB; Freedland SJ; Schaeffer EM; Dicker AP; Menon M; Briganti A; Davicioni E; Abdollah F
J Clin Oncol; 2017 Jun; 35(18):1982-1990. PubMed ID: 28350520
[TBL] [Abstract][Full Text] [Related]
10. Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.
Klein EA; Haddad Z; Yousefi K; Lam LL; Wang Q; Choeurng V; Palmer-Aronsten B; Buerki C; Davicioni E; Li J; Kattan MW; Stephenson AJ; Magi-Galluzzi C
Urology; 2016 Apr; 90():148-52. PubMed ID: 26809071
[TBL] [Abstract][Full Text] [Related]
11. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy.
Freedland SJ; Choeurng V; Howard L; De Hoedt A; du Plessis M; Yousefi K; Lam LL; Buerki C; Ra S; Robbins B; Trabulsi EJ; Shah NL; Abdollah F; Feng FY; Davicioni E; Dicker AP; Karnes RJ; Den RB
Eur Urol; 2016 Oct; 70(4):588-596. PubMed ID: 26806658
[TBL] [Abstract][Full Text] [Related]
12. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.
Ross AE; Den RB; Yousefi K; Trock BJ; Tosoian J; Davicioni E; Thompson DJ; Choeurng V; Haddad Z; Tran PT; Trabulsi EJ; Gomella LG; Lallas CD; Abdollah F; Feng FY; Klein EA; Dicker AP; Freedland SJ; Karnes RJ; Schaeffer EM
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):277-82. PubMed ID: 27136742
[TBL] [Abstract][Full Text] [Related]
14. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.
Erho N; Crisan A; Vergara IA; Mitra AP; Ghadessi M; Buerki C; Bergstralh EJ; Kollmeyer T; Fink S; Haddad Z; Zimmermann B; Sierocinski T; Ballman KV; Triche TJ; Black PC; Karnes RJ; Klee G; Davicioni E; Jenkins RB
PLoS One; 2013; 8(6):e66855. PubMed ID: 23826159
[TBL] [Abstract][Full Text] [Related]
15. Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.
Marascio J; Spratt DE; Zhang J; Trabulsi EJ; Le T; Sedzorme WS; Beeler WH; Davicioni E; Dabbas B; Lin DW; Gore JL; Bloom M; Mann M; Mark JR; Calvaresi A; Godwin JL; McCue P; Hurwitz MD; Kelly WK; Lallas CD; Knudsen KE; Gomella LG; Dicker AP; Den RB
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):295-302. PubMed ID: 31719663
[TBL] [Abstract][Full Text] [Related]
16. Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential.
Klein EA; Santiago-Jiménez M; Yousefi K; Robbins BA; Schaeffer EM; Trock BJ; Tosoian J; Haddad Z; Ra S; Karnes RJ; Jenkins RB; Cheville JC; Den RB; Dicker AP; Davicioni E; Freedland SJ; Ross AE
J Urol; 2017 Jan; 197(1):122-128. PubMed ID: 27569435
[TBL] [Abstract][Full Text] [Related]
17. Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting.
Glass AG; Leo MC; Haddad Z; Yousefi K; du Plessis M; Chen C; Choeurng V; Abdollah F; Robbins B; Ra S; Richert-Boe KE; Buerki C; Pearson K; Davicioni E; Weinmann S
J Urol; 2016 Jun; 195(6):1748-53. PubMed ID: 26626216
[TBL] [Abstract][Full Text] [Related]
18. Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.
Gore JL; du Plessis M; Santiago-Jiménez M; Yousefi K; Thompson DJS; Karsh L; Lane BR; Franks M; Chen DYT; Bandyk M; Bianco FJ; Brown G; Clark W; Kibel AS; Kim HL; Lowrance W; Manoharan M; Maroni P; Perrapato S; Sieber P; Trabulsi EJ; Waterhouse R; Davicioni E; Lotan Y; Lin DW
Cancer; 2017 Aug; 123(15):2850-2859. PubMed ID: 28422278
[TBL] [Abstract][Full Text] [Related]
19. Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients.
Den RB; Santiago-Jimenez M; Alter J; Schliekelman M; Wagner JR; Renzulli Ii JF; Lee DI; Brito CG; Monahan K; Gburek B; Kella N; Vallabhan G; Abdollah F; Trabulsi EJ; Lallas CD; Gomella LG; Woodlief TL; Haddad Z; Lam LL; Deheshi S; Wang Q; Choeurng V; du Plessis M; Jordan J; Parks B; Shin H; Buerki C; Yousefi K; Davicioni E; Patel VR; Shah NL
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):374-379. PubMed ID: 27574020
[TBL] [Abstract][Full Text] [Related]
20. Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.
Lalonde E; Alkallas R; Chua MLK; Fraser M; Haider S; Meng A; Zheng J; Yao CQ; Picard V; Orain M; Hovington H; Murgic J; Berlin A; Lacombe L; Bergeron A; Fradet Y; Têtu B; Lindberg J; Egevad L; Grönberg H; Ross-Adams H; Lamb AD; Halim S; Dunning MJ; Neal DE; Pintilie M; van der Kwast T; Bristow RG; Boutros PC
Eur Urol; 2017 Jul; 72(1):22-31. PubMed ID: 27815082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
